Atsou KM, Rachet B, Cornet E, Chretien ML, Rossi C, Remontet L, Roche L, Giorgi R, Gauthier S, Girard S, Böckle J, Wasse SK, Rachou H, Bouzid L, Poncet JM, Orazio S, Monnereau A, Troussard X, Mounier M, Maynadie M

Cancer Med. 2023 01 29;:

Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database.

Cottin Y, Boulin M, Doisy C, Mounier M, Caillot D, Chretien ML, Bodin A, Herbert J, Bonnotte B, Zeller M, Maynadié M, Fauchier L

Cancers (Basel). 2022 06 21;14(13):

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R, ,

Lancet Haematol. 2015 Nov;2(11):e481-91

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.

Lang AS, Mounier M, Roques M, Chretien ML, Boulin M

J Clin Pharm Ther. 2015 Aug;40(4):391-7

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.

Alkadah A, Thiam F, Mounier M, Charpilienne A, Poncet D, Kohli E, Basset C

Vaccine. 2013 Apr 8;31(15):1924-30

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr MOUNIER Morgane

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Projets

Etude de la survie nette des LAM et de ses déterminants

Publications

Multidimensional penalized splines for survival models: illustration for net survival trend analyses.

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study.

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.

Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database.

Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.

Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM.

Hematological Malignancies in Giant Cell Arteritis: a French population-based study.

Evans' Syndrome: From Diagnosis to Treatment.

Time-to-cure and cure proportion in solid cancers in France. A population based study.

A new approach to estimate time-to-cure from cancer registries data.

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.

Retrouvez aussi